IBDEI2B0 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,39085,1,3,0)
 ;;=3^Urticaria,Other Spec
 ;;^UTILITY(U,$J,358.3,39085,1,4,0)
 ;;=4^L50.8
 ;;^UTILITY(U,$J,358.3,39085,2)
 ;;=^5009203
 ;;^UTILITY(U,$J,358.3,39086,0)
 ;;=L50.0^^151^1917^2
 ;;^UTILITY(U,$J,358.3,39086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39086,1,3,0)
 ;;=3^Urticaria,Allergic
 ;;^UTILITY(U,$J,358.3,39086,1,4,0)
 ;;=4^L50.0
 ;;^UTILITY(U,$J,358.3,39086,2)
 ;;=^5009200
 ;;^UTILITY(U,$J,358.3,39087,0)
 ;;=L50.6^^151^1917^3
 ;;^UTILITY(U,$J,358.3,39087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39087,1,3,0)
 ;;=3^Urticaria,Contact
 ;;^UTILITY(U,$J,358.3,39087,1,4,0)
 ;;=4^L50.6
 ;;^UTILITY(U,$J,358.3,39087,2)
 ;;=^5009202
 ;;^UTILITY(U,$J,358.3,39088,0)
 ;;=L50.2^^151^1917^1
 ;;^UTILITY(U,$J,358.3,39088,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39088,1,3,0)
 ;;=3^Urticaria d/t Cold/Heat
 ;;^UTILITY(U,$J,358.3,39088,1,4,0)
 ;;=4^L50.2
 ;;^UTILITY(U,$J,358.3,39088,2)
 ;;=^271938
 ;;^UTILITY(U,$J,358.3,39089,0)
 ;;=L56.3^^151^1917^5
 ;;^UTILITY(U,$J,358.3,39089,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39089,1,3,0)
 ;;=3^Urticaria,Solar
 ;;^UTILITY(U,$J,358.3,39089,1,4,0)
 ;;=4^L56.3
 ;;^UTILITY(U,$J,358.3,39089,2)
 ;;=^5009217
 ;;^UTILITY(U,$J,358.3,39090,0)
 ;;=B02.8^^151^1918^1
 ;;^UTILITY(U,$J,358.3,39090,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39090,1,3,0)
 ;;=3^Zoster w/ Other Complications
 ;;^UTILITY(U,$J,358.3,39090,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,39090,2)
 ;;=^5000500
 ;;^UTILITY(U,$J,358.3,39091,0)
 ;;=B02.9^^151^1918^2
 ;;^UTILITY(U,$J,358.3,39091,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39091,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,39091,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,39091,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,39092,0)
 ;;=Q3014^^152^1919^5^^^^1
 ;;^UTILITY(U,$J,358.3,39092,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39092,1,2,0)
 ;;=2^Q3014
 ;;^UTILITY(U,$J,358.3,39092,1,3,0)
 ;;=3^TELEHEALTH FACILITY FEE
 ;;^UTILITY(U,$J,358.3,39093,0)
 ;;=92227^^152^1919^3^^^^1
 ;;^UTILITY(U,$J,358.3,39093,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39093,1,2,0)
 ;;=2^92227
 ;;^UTILITY(U,$J,358.3,39093,1,3,0)
 ;;=3^REMOTE DX RETINAL IMAGING
 ;;^UTILITY(U,$J,358.3,39094,0)
 ;;=92228^^152^1919^4^^^^1
 ;;^UTILITY(U,$J,358.3,39094,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39094,1,2,0)
 ;;=2^92228
 ;;^UTILITY(U,$J,358.3,39094,1,3,0)
 ;;=3^REMOTE IMAGING-RETINAL MGMT
 ;;^UTILITY(U,$J,358.3,39095,0)
 ;;=92250^^152^1919^1^^^^1
 ;;^UTILITY(U,$J,358.3,39095,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39095,1,2,0)
 ;;=2^92250
 ;;^UTILITY(U,$J,358.3,39095,1,3,0)
 ;;=3^FUNDUS PHOTO W/ INTERP & RPT
 ;;^UTILITY(U,$J,358.3,39096,0)
 ;;=T1014^^152^1919^6^^^^1
 ;;^UTILITY(U,$J,358.3,39096,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39096,1,2,0)
 ;;=2^T1014
 ;;^UTILITY(U,$J,358.3,39096,1,3,0)
 ;;=3^TELEHEALTH TRANSMIT, PER MIN
 ;;^UTILITY(U,$J,358.3,39097,0)
 ;;=3072F^^152^1919^2^^^^1
 ;;^UTILITY(U,$J,358.3,39097,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,39097,1,2,0)
 ;;=2^3072F
 ;;^UTILITY(U,$J,358.3,39097,1,3,0)
 ;;=3^LOW RISK FOR RETINOPATHY
 ;;^UTILITY(U,$J,358.3,39098,0)
 ;;=B02.33^^153^1920^164
 ;;^UTILITY(U,$J,358.3,39098,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39098,1,3,0)
 ;;=3^Zoster Keratitis
 ;;^UTILITY(U,$J,358.3,39098,1,4,0)
 ;;=4^B02.33
 ;;^UTILITY(U,$J,358.3,39098,2)
 ;;=^5000496
 ;;^UTILITY(U,$J,358.3,39099,0)
 ;;=B02.32^^153^1920^163
 ;;^UTILITY(U,$J,358.3,39099,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,39099,1,3,0)
 ;;=3^Zoster Iridocyclitis
 ;;^UTILITY(U,$J,358.3,39099,1,4,0)
 ;;=4^B02.32
